Gene · 10278
Papers1,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibiting TNAP Attenuates the Aortic Valve Calcification and Reduces Oxidative Stress. | Cells | 2026 | 42738837 | PubTator, text mining | PubMed |
| Environmentally friendly solvents: the strategic and frontier fields of natural product extraction. | Food Chem | 2026 | 42721589 | PubTator, text mining | PubMed |
| Diverse routes to Cas3 activation in type I CRISPR-Cas immunity. | Cell Rep | 2026 | 42721033 | PubTator, text mining | PubMed |
| Recruitment of Cas3 enables DNA cleavage by the type I-A CRISPR-Cas system of Saccharolobus islandicus. | Cell Rep | 2026 | 42570236 | PubTator, text mining | PubMed |
| CRISPR-Cas systems as precision antimicrobials: Reversing the tide of antimicrobial resistance. | Virus Res | 2026 | 42551559 | PubTator, text mining | PubMed |
| Synergistic Inhibition of Colorectal Cancer Growth by Combined PI3K and COX-2 Blockade in Cell Lines and Patient-Derived Organoids. | Pharmaceutics | 2026 | 42357299 | PubTator, text mining | PubMed |
| Gigabase-scale deletion scanning of the human genome. | bioRxiv | 2026 | 42282737 | PubTator, text mining | PubMed |
| The effects of external electric fields on proteins. | Chem Soc Rev | 2026 | 41995174 | PubTator, text mining | PubMed |
Correction: Sarman, E.; Asci, H. Cellular Anti-Apoptotic Effects of Dapagliflozin in Methotrexate-Induced Liver Toxicity: Bax/Bcl-2/Cyt-C/Cas-9/Cas-3 Signaling Pathway. Int. J. Mol. Sci. 2026, 27, 2110. | Int J Mol Sci | 2026 | 41977518 | PubTator, text mining | PubMed |
| Targeting mitochondrial apoptosis in septic lung injury: protective potential of omega-3 fatty acids. | Apoptosis | 2026 | 41894027 | PubTator, text mining | PubMed |
| Synthesis and Characterization of Juglone-Derived cu (II), Mn (II) and Zn (II) Complexes and Investigation of Their Cytotoxic Activities Against Lung and Colon Cancer Cells in Vitro and in Silico. | J Appl Toxicol | 2026 | 41883096 | PubTator, text mining | PubMed |
| Autophagy inhibition potentiates the antileukemic effect of FLT3 inhibitors and overcomes resistance in FLT3-ITD acute myeloid leukemia. | Cell Death Discov | 2026 | 41876469 | PubTator, text mining | PubMed |
| A targeting lentiviral vector for generation of CAR-T cells in vivo. | Sci Rep | 2026 | 41844687 | PubTator, text mining | PubMed |
| The accumulation of technical errors exponentially increases the risk of screw cut-out in femoral intramedullary nailing. | Arch Orthop Trauma Surg | 2026 | 41801471 | PubTator, text mining | PubMed |
| Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies. | J Pharm Anal | 2026 | 41798069 | PubTator, text mining | PubMed |
| Molecular Insights into the Immunomodulating and Anticancer Mechanisms of Eremina desertorum (Forsskal, 1775) Mucin in HepG-2 and CACO-2 Cells. | Asian Pac J Cancer Prev | 2026 | 41793661 | PubTator, text mining | PubMed |
| Structural basis of Cas8-independent Cas3 recruitment in Type I-F2 CRISPR-Cas. | Nucleic Acids Res | 2026 | 41761908 | PubTator, text mining | PubMed |
| Impact of transport modality on time to endovascular thrombectomy : A population-based registry study in rural Sweden. | Scand J Trauma Resusc Emerg Med | 2026 | 41749283 | PubTator, text mining | PubMed |
| Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial. | ESMO Open | 2026 | 41747586 | PubTator, text mining | PubMed |
| Phylogenomic analysis of Paracidovorax citrulli strains reveals the presence of two lineages in Brazil. | Genet Mol Biol | 2026 | 41740027 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10278/papers